Patricia Leuchten

Founder and former CEO, WCG Avoca and Founder and CEO
Diligent Pharma
 

 

Patricia Leuchten is Founder of WCG Avoca and Founder and CEO of Diligent Pharma. She has more than 30 years of experience in the pharmaceutical industry and is a leading authority on global clinical outsourcing, strategic alliances and driving change in clinical trial execution through collaboration.

In 1999, she founded The Avoca Group, a consulting and research firm focused on the elevation of quality in clinical trial execution. The Avoca Group has played an important role in the industry as the first consulting firm to track trends in clinical research and clinical outsourcing and to measure the health of relationships between sponsors and CROs. In 2011, Patricia launched the Avoca Quality Consortium a member-based, pre-competitive collaborative comprised of clinical operations, quality, and outsourcing professionals from pharma, biotech, CROs, and clinical service providers. Since its inception, the rapidly growing Avoca Quality Consortium is transforming clinical development by driving efficiency, improving quality, and mitigating risk in clinical trial execution. In 2019, Patricia launched Diligent Pharma, The Diligent Qualification Platform (DQP) is a centralized technology platform for streamlining vendor qualification in clinical trial execution. Diligent is transforming the current approach to identifying and qualifying clinical trial vendors and is driving innovation while mitigating risks and addressing the need for speed and high quality in the process.

Patricia is a frequent speaker and writer on topics surrounding clinical outsourcing, strategic alliances, quality management and relationship management in the pharmaceutical industry.